Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L.K. Mittal
Reimbursement Decision Landscape for Orphan Drugs Across Six Hta Agencies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Psy185 - Alternative Methodologies Implemented by Hta Agencies for Orphan Drugs: A Scoping Review
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Are Orphan Drugs Treated the Same Across Europe: An Hta Case Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Hta Studies on Orphan Drugs by Rebratsxmembers
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Bridging HTA Agencies Across Europe: A Systematic Approach to Categorize Evolving Agencies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Reimbursement of Orphan Drugs in Belgium: What (Else) Matters?
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
Pricing and Reimbursement of Orphan Drugs: The Need for More Transparency
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
Psy147 - Availability and Reimbursement of Orphan Drugs in the Czech Republic
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Reimbursement of Orphan Drugs: The Pompe and Fabry Case in the Netherlands
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
Psy180 - Uk Health Technology Assessment of Orphan Drugs for Rare Oncology Versus Rare Disease: Does Orphan Designation Make Any Difference in Hta Process?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
